Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy

被引：0
|
作者：
K Ishikawa
S Honda
Y Tsukahara
A Negi
机构：
[1] Kobe University Graduate School of Medicine,Department of Surgery, Division of Ophthalmology
来源：
Eye | 2009年 / 23卷
关键词：
proliferative diabetic retinopathy; bevacizumab; vitrectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：108 / 111
页数：3
相关论文
共 50 条
  • [31] Intravitreal bevacizumab for persistent macular edema with proliferative diabetic retinopathy
    Gulkilik G.
    Taskapili M.
    Kocabora S.
    Muftuoglu G.
    Demirci G.
    International Ophthalmology, 2010, 30 (6) : 697 - 702
  • [32] Bevacizumab (Avastin) as an Adjunct to Vitrectomy in the Management of Severe Proliferative Diabetic Retinopathy: A Prospective Case Series
    Abdelhakim, Mohamad Amr Salah Eddin
    Macky, Tamer A.
    Mansour, Khaled Abdel Galil
    Mortada, Hassan Ali
    OPHTHALMIC RESEARCH, 2011, 45 (01) : 23 - 30
  • [33] The adjunctive use of pre-operative intravitreal bevacizumab in the setting of proliferative diabetic retinopathy
    Al-Kharashi, Abdullah
    Galbinur, Tural
    Mandelcorn, Efrem D.
    Muni, Rajeev H.
    Nabavi, Mir
    Kertes, Peter J.
    SAUDI JOURNAL OF OPHTHALMOLOGY, 2016, 30 (04) : 217 - 220
  • [34] Retinal detachment with macular hole following intravitreal bevacizumab in patient with severe proliferative diabetic retinopathy
    Mitamura, Yoshinori
    Ogata, Kazuha
    Oshitari, Toshiyuki
    Asaumi, Noriko
    Yamamoto, Shuichi
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (05) : 717 - 718
  • [35] Vitrectomy With or Without Preoperative Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy: A Meta-Analysis of Randomized Controlled Trials
    Zhang, Zhi-Hua
    Liu, Hai-Yun
    Hernandez-Da Mota, Sergio E.
    Romano, Mario R.
    Falavarjani, Khalil G.
    Ahmadieh, Hamid
    Xu, Xun
    Liu, Kun
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 156 (01) : 106 - 115
  • [36] Ghost Cell Glaucoma After Intravitreal Bevacizumab for Postoperative Vitreous Hemorrhage Following Vitrectomy for Proliferative Diabetic Retinopathy
    Lin, Laura
    Wu, Wei-Chi
    Yeung, Ling
    Wang, Nan-Kai
    Kuo, Ya-Hui
    Chao, An-Ning
    Chen, Kuan-Jen
    Chen, Ten-Lu
    Lai, Chi-Chun
    Hwang, Yih-Shiou
    Chen, Yen-Po
    OPHTHALMIC SURGERY LASERS & IMAGING, 2010, 41 (01) : 72 - 77
  • [37] Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy
    Arevalo, J. F.
    Maia, M.
    Flynn, H. W., Jr.
    Saravia, M.
    Avery, R. L.
    Wu, L.
    Farah, M. Eid
    Pieramici, D. J.
    Berrocal, M. H.
    Sanchez, J. G.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (02) : 213 - 216
  • [38] Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy
    Mao, Jian-Bo
    Wu, Han-Fei
    Chen, Yi-Qi
    Zhao, Shi-Xin
    Tao, Ji-Wei
    Zhang, Yun
    Zheng, Bin
    Wang, Lin
    Shen, Li-Jun
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2018, 11 (07) : 1217 - 1221
  • [39] The effect and safety of intravitreal ranibizumab combined with vitrectomy for proliferative diabetic retinopathy
    Rong, Hua
    Xu, Yueli
    Zhang, Meiping
    Cai, Minyun
    Cui, Hongping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (04): : 7163 - 7167
  • [40] Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy
    Jian-Bo Mao
    Han-Fei Wu
    Yi-Qi Chen
    Shi-Xin Zhao
    Ji-Wei Tao
    Yun Zhang
    Bin Zheng
    Lin Wang
    Li-Jun Shen
    International Journal of Ophthalmology, 2018, (07) : 1217 - 1221
12345